While the company is showing early signs of recovery and margin improvement, a high valuation means risks remain.

Avoidable deaths are on the rise as Nigeria’s blood banks fail to deliver blood to patients requiring transfusion to survive.

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

Infectious disease clinicians raised alarm that proposed cuts to Medicaid could affect ID-related services, not only among ...

A new study found that implementing a specialty pharmacy program at St. Jude Children’s Research Hospital helped more young HIV patients achieve medication adherence and undetectable viral loads.

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.

We are dying!” the group chanted. The protesters risked being shunned by society to warn that Haiti is running out of HIV medication just months after the administration of U.S. President Donald ...

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

Gilead’s HIV treatment trials involving an investigational integrase strand inhibitor (GS-1720) and an investigational capsid inhibitor (GS-4182) have been put on clinical hold by the Food and Drug ...

What is the history of the AIDS epidemic, when did treatment become widely available, and what are the current goals for ending this epidemic?